Highly Potent Active Pharmaceutical Ingredients Summit

This premier B2B event will enable the participants to learn about the latest developments in the HPAPI Industry.

5 6 November 2015

Currently in read only mode, sorry about that, please try again in a few hours.

6 speakers

  • Andreas Schreiner Director of Validation, Manufacturing Science Novartis Ag
  • Wendel Doubleday Director, Process Research & Development, Seattle Genetics
  • Greg Erexson Principal Toxicologist, Preclinical Safety, Development Sciences, Global Pharmaceuticals R&D, AbbVie
  • Jason Hamm Director - Chemical Development Operations at Bristol-Myers Squibb

6 known attendees

  • Maia Pedro
  • Wendel Doubleday
  • Greg Erexson
  • Jason Hamm
  • Jeffrey Sperry
  • Justin Mason-Home

Tell your friends!

Share this event with your friends on Twitter


Claimed event

This event has been claimed


See something wrong?

Report an issue with this event